Lester Rachael has filed 4 insider transactions across 1 company since October 2025.
Most recent transaction: a grant/award of 20000 shares of CytomX Therapeutics, Inc. ($CTMX) on February 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 2, 2026 | CytomX Therapeutics, Inc. | $CTMX | Lester Rachael | Chief Business Officer | A | Common Stock | 20000 | $0.00 | 20,000.0000 | 169,435,395 | 9999.99% | 0.01% |
| Feb. 2, 2026 | CytomX Therapeutics, Inc. | $CTMX | Lester Rachael | Chief Business Officer | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 169,435,395 | 9999.99% | 0.03% |
| Feb. 2, 2026 | CytomX Therapeutics, Inc. | $CTMX | Lester Rachael | Chief Business Officer | A | Performance Stock Units (PSUs) | 50000 | $0.00 | 50,000.0000 | 169,435,395 | 9999.99% | 0.03% |
| Oct. 20, 2025 | CytomX Therapeutics, Inc. | $CTMX | Lester Rachael | Chief Business Officer | A | Stock Option (Right to Buy) | 650000 | $0.00 | 650,000.0000 | 80,099,889 | 9999.99% | 0.81% |